Novarcel Group Limited is an investment company focusing on early and growth stage innovative biotechnology and pharmaceutical companies worldwide. Novarcel adopts a global vision to bridge emerging market in China, global financial resources, and therapeutic breakthroughs worldwide. We seek to create and invest in companies whose technology and products can address unmet medical needs and improve quality of life. Novarcel team has extensive industry experiences including R&D, business development, operation, and management in US and China??s pharma, biotech, CRO, and service companies. We aim to be actively involved in helping portfolio companies to grow through various stages and to successfully deliver the breakthrough cures to patients worldwide.